2023
|
Invention
|
Benzopyrimidin-4(3h)-ones as pi3k inhibitors. 177 are as defined. |
|
Invention
|
((4-oxo-3,4-dihydroquinazolin-8-yl)methyl)amine derivatives as p13k inhibitors for the treatment ... |
|
Invention
|
Hdac inhibitor oki-179 for the treatment of cancers resulting from a mapk pathway mutation. OKI-1... |
|
Invention
|
Isoquinolones as pi3k inhibitors. 188 are as defined. |
|
Invention
|
Process for the preparation of cyclic depsipeptides.
Processes for preparing compounds of Formul... |
|
Invention
|
Benzopyrimidin-4(3h)-ones as pi3k inhibitors. Novel PI3K inhibitors of the general Formula (1) ar... |
|
Invention
|
Hdac inhibitor oki-179 in combination with binimetinib for the treatment of cancer. A method of t... |
2021
|
Invention
|
Thioester prodrugs of macrocycles as inhibitors of histone deacetylases.
The present invention p... |
|
Invention
|
Process for the preparation of cyclic depsipeptides. 7, L and n are defined herein. Intermediates... |
2020
|
Invention
|
Benzimidazole compounds as hdac6 inhibitors. 2 are as described.
|
|
Invention
|
Benzimidazole compounds as hdac6 inhibitors. 12122 are as described. |
2019
|
P/S
|
Pharmaceutical research and development; Scientific research and development |
2017
|
Invention
|
Thioester prodrugs of macrocycles as inhibitors of histone deacetylases. 11, A and Z are defined ... |
|
Invention
|
Thioester prodrugs of macrocycles as inhibitors of histone deacetylases. The present invention pr... |
2015
|
Invention
|
Process for the preparation of cyclic depsipeptides. Processes for preparing compounds of Fommla ... |
|
Invention
|
Process for the preparation of cyclic depsipeptides. Processes for preparing compounds of Formula... |